---
title: seronegative spondyloarthritis
alias: SpA
date: "2023-01-17"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[rheumatology]]

# seronegative spondyloarthritis

- [[Definition and classification system of seronegative spondyloarthritis|Definition and classification system]] ó°’–
- Epidemiology & pathogenesis (Nat Rev Rheumatol 2015;11:110)
  - Prevalence 1/200 to 1/50 worldwide; AS and non-radiographic axial SpA most common
  - HLA-B27 accounts for ~30% of attributable genetic risk but not required for diagnosis
  - Environmental factors likely critical for disease, esp reactive arthritis (ie, infection)
- [[Spondyloarthritis (SpA) Epidemiology and Key Presentation Features]]
- [[Major clinical manifestations of seronegative spondyloarthritis|Major clinical manifestations]] ó°’–
- [[Distinguishing Features of seronegative spondyloarthritis|Distinguishing Features]] ó°’–
- [[Clinical assessment of seronegative spondyloarthritis|Clinical assessment]] ó°’–
- [[Descriptions of skin manifestations of seronegative spondyloarthritis|Descriptions of skin manifestations]] ó°’–
- [[Psoriatic arthritis subtypes]]
- [[Treatment approach of seronegative spondyloarthritis|Treatment approach]] ó°’–
